好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Predicting Success in Neurology Residency
Neurologic 好色先生
S27 - (-)
003
Few studies have investigated the relationship between resident background and performance in the ACGME competencies during residency.
Resident files (n = 224) from 1962 to 2011 from the Upstate Medical University Neurology Residency were reviewed. De-identified data were used to compare USMLE Step 1 scores and pre-residency interview scores with residency in-training examination (RITE) scores, competency-based 360 and attending evaluations during residency. Pearson coefficients and independent t-tests were calculated to assess the relationships between tests.
USMLE 1 scores were positively correlated with RITE scores (p < .0005, R = .52) and with medical knowledge (MK), patient care (PC) and professionalism scores during residency (p < 0.005, R = 0.35, 0.41, .35.) Residents earning interview scores of 4 or 5(of 5) were significantly more likely to be rated higher on evaluations in professionalism (p = .033), PC (p = .004), and MK (p = .032), during the first year of residency but not in system-based practice (SBP), practice-based learning (PBL) or interpersonal communication skills (ICS). They were less likely to be put on probation (p = .005) than those ranked 3 or lower. Residents placed on probation during residency were significantly more likely to have had lower USMLE 1 scores than those who were not (p = .004).
High USMLE scores correlated with higher levels of professionalism, MK, PC and RITE performance during residency. Candidates scored as "very good" or "exceptional" by faculty interviewers were less likely to be deemed clinically deficient, put on probation, or fired than candidates with lower interview scores. USMLE 1 and interview scores predict performance in professionalism, MK and PC during Neurology residency. Other measures are needed to predict performance in the SBP, PBL and ICS competencies.
Authors/Disclosures

PRESENTER 		No disclosure on file
Deborah Y. Bradshaw, MD, FAAN (SUNY Upstate Medical University) The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
No disclosure on file
Anthony Traboulsee, MD (University of British Columbia) Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.